Department of Science and Technology , University of Sannio , via dei Mulini , 82100 Benevento , Italy.
Novus Scientific AB , Virdings allé 2 , 754 50 Uppsala , Sweden.
Biomacromolecules. 2019 Apr 8;20(4):1465-1477. doi: 10.1021/acs.biomac.9b00159. Epub 2019 Mar 20.
The history of resorbable polymers containing glycolide, lactide, ε-caprolactone and trimethylene carbonate, with a special emphasis being placed on the time frame of the 1960s-1990s is described. Reviewing the history is valuable when looking into the future perspectives regarding how and where these monomers should be used. This story includes scientific evaluations indicating that these polymers are safe to use in medical devices, while the design of the medical device is not considered in this report. In particular, we present the data regarding the tissue response to implanted polymers, as well as the toxicity and pharmacokinetics of their degradation products. In the translation of these polymers from "the bench to the bedside," various challenges have been faced by surgeons, medical doctors, biologists, material engineers and polymer chemists. This Perspective highlights the visionary role played by the pioneers, addressing the problems that occurred on a case by case basis in translational medicine.
本文描述了含有乙交酯、丙交酯、ε-己内酯和三亚甲基碳酸酯的可吸收聚合物的历史,特别强调了 20 世纪 60 年代至 90 年代这一时期。回顾历史对于研究这些单体应该如何以及在何处使用具有重要意义。这一历史包括科学评估,表明这些聚合物在医疗器械中使用是安全的,而本报告未考虑医疗器械的设计。特别地,我们提供了关于植入聚合物的组织反应以及其降解产物的毒性和药代动力学的数据。在将这些聚合物从“实验室走向临床”的过程中,外科医生、内科医生、生物学家、材料工程师和聚合物化学家面临着各种挑战。本观点强调了先驱者的有远见的作用,解决了转化医学中逐个案例出现的问题。